LSP-249

CAS No. 1801253-04-2

LSP-249( —— )

Catalog No. M23814 CAS No. 1801253-04-2

LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
2MG 38 In Stock
5MG 61 In Stock
10MG 92 In Stock
25MG 187 In Stock
50MG 305 In Stock
100MG 500 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LSP-249
  • Note
    Research use only, not for human use.
  • Brief Description
    LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
  • Description
    LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    kallikrein
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801253-04-2
  • Formula Weight
    431.92
  • Molecular Formula
    C24H22ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:31.25 mg/mL?(69.45 mM;?ultrasonic and warming and heat to 60°C)
  • SMILES
    Cc1cc(N)nc(C)c1CNC(c1cc(Cc2ccc3ncc(Cl)cc3c2)ncc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.
molnova catalog
related products
  • pTH (1-31) (human)

    Human PTH-(1-31) is the 1-31 fragment of human PTH. Human PTH-(1-31) stimulates the release of cAMP and also is a weaker stimulator of the 25-hydroxyvitamin D-1α-hydroxylase. Human PTH-(1-31) induces bone formation without inducing bone resorption. Human PTH-(1-31) has the potential for the research of osteoporosis.

  • Biotin-PEG2-CH2CH2N3

    Biotin-PEG2-CH2CH2N3 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • 5,7,3-Trihydroxy-6,4...

    5,7,3'-Trihydroxy-6,4',5'-trimethoxyflavone is a natural product from Artemisia argyi.